Kazuhisa Nakashima

Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Hironobu Hashimoto, Masakazu Abé, Osamu Tokuyama et al. · The Lancet Oncology · 2019 · 235 citations

Medicine, Pharmacology, Pharmacotherapy +16

Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure

Takahisa Kawamura, Hirotsugu Kenmotsu, Tetsuhiko Taira et al. · Cancer Science · 2016 · 92 citations · Full text

Medicine, Oncology, Pathology +15

Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer

Tateaki Naito, Taro Okayama, Takashi Aoyama et al. · BMC Cancer · 2017 · 77 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study

Tateaki Naito, Taro Okayama, Takashi Aoyama et al. · BMC Cancer · 2017 · 63 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases

Eriko Miyawaki, Hirotsugu Kenmotsu, Keita Mori et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 59 citations

Medicine, Oncology, Metastasis +15